Neuronetics, Inc. (STIM)
STIM Stock Price Chart
Explore Neuronetics, Inc. interactive price chart. Choose custom timeframes to analyze STIM price movements and trends.
STIM Company Profile
Discover essential business fundamentals and corporate details for Neuronetics, Inc. (STIM) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
28 Jun 2018
Employees
716.00
Website
https://www.neurostar.comCEO
Daniel L. Reuvers
Description
Neuronetics, Inc. functions as a medical technology enterprise with commercialized products, specializing in the creation, enhancement, and global distribution of solutions for individuals experiencing neurohealth conditions, both within the U.S. and abroad. The company's flagship product is the NeuroStar Advanced Therapy System, an in-office, non-surgical, and non-pharmaceutical treatment option available for adult patients diagnosed with major depressive disorder. This sophisticated system utilizes transcranial magnetic stimulation (TMS) to generate a pulsed magnetic field, similar in strength to an MRI, which subsequently induces electrical currents. These currents are specifically engineered to activate brain areas that are key to mood regulation. Neuronetics distributes its offerings directly to psychiatrists through its dedicated sales and client support personnel. Established in 2001, the company's corporate headquarters are situated in Malvern, Pennsylvania.
STIM Financial Timeline
Browse a chronological timeline of Neuronetics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 4 Aug 2026
EPS estimate is -$0.11, while revenue estimate is $40.09m.
Earnings released on 5 May 2026
EPS came in at -$0.16 surpassing the estimated -$0.17 by +5.88%, while revenue for the quarter reached $34.45m , beating expectations by +0.84%.
Earnings released on 17 Mar 2026
EPS came in at -$0.10 surpassing the estimated -$0.12 by +16.67%, while revenue for the quarter reached $41.78m , beating expectations by +2.72%.
Earnings released on 4 Nov 2025
EPS came in at -$0.13 falling short of the estimated -$0.12 by -8.33%, while revenue for the quarter reached $37.30m , missing expectations by -1.45%.
Earnings released on 5 Aug 2025
EPS came in at -$0.15 falling short of the estimated -$0.08 by -87.50%, while revenue for the quarter reached $38.11m , beating expectations by +0.69%.
Earnings released on 6 May 2025
EPS came in at -$0.21 falling short of the estimated -$0.13 by -61.54%, while revenue for the quarter reached $31.98m , missing expectations by -12.63%.
Earnings released on 4 Mar 2025
EPS came in at -$0.33 falling short of the estimated -$0.26 by -26.92%, while revenue for the quarter reached $22.49m , missing expectations by -21.90%.
Earnings released on 12 Nov 2024
EPS came in at -$0.29 falling short of the estimated -$0.23 by -26.09%, while revenue for the quarter reached $18.53m , missing expectations by -3.14%.
Earnings released on 12 Aug 2024
EPS came in at -$0.33 falling short of the estimated -$0.27 by -22.22%, while revenue for the quarter reached $16.45m , missing expectations by -11.80%.
Earnings released on 7 May 2024
EPS came in at -$0.27 surpassing the estimated -$0.33 by +18.18%, while revenue for the quarter reached $17.42m , beating expectations by +1.73%.
Earnings released on 5 Mar 2024
EPS came in at -$0.19 surpassing the estimated -$0.26 by +26.92%, while revenue for the quarter reached $20.31m , beating expectations by +2.34%.
Earnings released on 7 Nov 2023
EPS came in at -$0.33 falling short of the estimated -$0.30 by -10.00%, while revenue for the quarter reached $17.88m , missing expectations by -9.49%.
Earnings released on 8 Aug 2023
EPS came in at -$0.17 surpassing the estimated -$0.34 by +50.00%, while revenue for the quarter reached $17.61m , beating expectations by +1.32%.
Earnings released on 9 May 2023
EPS came in at -$0.38 surpassing the estimated -$0.39 by +2.56%, while revenue for the quarter reached $15.54m , beating expectations by +2.37%.
Earnings released on 7 Mar 2023
EPS came in at -$0.30 surpassing the estimated -$0.43 by +30.23%, while revenue for the quarter reached $18.20m , beating expectations by +8.19%.
Earnings released on 8 Nov 2022
EPS came in at -$0.28 surpassing the estimated -$0.44 by +36.36%, while revenue for the quarter reached $16.50m , beating expectations by +9.87%.
Earnings released on 2 Aug 2022
EPS came in at -$0.39 surpassing the estimated -$0.43 by +9.30%, while revenue for the quarter reached $16.33m , beating expectations by +5.64%.
Earnings released on 12 May 2022
EPS came in at -$0.41 matching the estimated -$0.41, while revenue for the quarter reached $14.18m , beating expectations by +5.36%.
Earnings released on 8 Mar 2022
EPS came in at -$0.29 surpassing the estimated -$0.33 by +12.12%, while revenue for the quarter reached $15.02m , beating expectations by +4.05%.
Earnings released on 9 Nov 2021
EPS came in at -$0.31 falling short of the estimated -$0.28 by -10.71%, while revenue for the quarter reached $13.80m , missing expectations by -8.43%.
Earnings released on 3 Aug 2021
EPS came in at -$0.29 falling short of the estimated -$0.24 by -20.83%, while revenue for the quarter reached $14.20m , meeting expectations.
STIM Stock Performance
Access detailed STIM performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
